937 related articles for article (PubMed ID: 19386548)
1. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC).
Gregor A; Cull A; Stephens RJ; Kirkpatrick JA; Yarnold JR; Girling DJ; Macbeth FR; Stout R; Machin D
Eur J Cancer; 1997 Oct; 33(11):1752-8. PubMed ID: 9470828
[TBL] [Abstract][Full Text] [Related]
3. Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Kubota K; Hida T; Ishikura S; Mizusawa J; Nishio M; Kawahara M; Yokoyama A; Imamura F; Takeda K; Negoro S; Harada M; Okamoto H; Yamamoto N; Shinkai T; Sakai H; Matsui K; Nakagawa K; Shibata T; Saijo N; Tamura T;
Lancet Oncol; 2014 Jan; 15(1):106-13. PubMed ID: 24309370
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N
Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of accelerated chest irradiation and impact on survival of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer: review of a single institution's experience.
Ng M; Chong J; Milner A; MacManus M; Wheeler G; Wirth A; Michael M; Ganju V; McKendrick J; Ball D
J Thorac Oncol; 2007 Jun; 2(6):506-13. PubMed ID: 17545845
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
7. The role of prophylactic brain irradiation in small cell lung cancer treatment.
Sørensen JB
Monaldi Arch Chest Dis; 2003; 59(2):128-33. PubMed ID: 14635501
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission.
Cao KJ; Huang HY; Tu MC; Pan GY
Chin Med J (Engl); 2005 Aug; 118(15):1258-62. PubMed ID: 16117878
[TBL] [Abstract][Full Text] [Related]
9. Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung.
Rubenstein JH; Dosoretz DE; Katin MJ; Blitzer PH; Salenius SA; Floody PA; Harwin WN; Teufel TE; Raymond MG; Reeves JA
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):329-37. PubMed ID: 7673020
[TBL] [Abstract][Full Text] [Related]
10. Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancer.
Chen Y; Li J; Zhang Y; Hu Y; Zhang G; Yan X; Lin Z; Zhao Z; Jiao S
Strahlenther Onkol; 2018 Oct; 194(10):876-885. PubMed ID: 29774395
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Alshehadat S; Sahmoun AE
Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C; Pourel N; Barlesi F; Lerouge D; Antoni D; Lamezec B; Nestle U; Boisselier P; Dansin E; Paumier A; Peignaux K; Thillays F; Zalcman G; Madelaine J; Pichon E; Larrouy A; Lavole A; Argo-Leignel D; Derollez M; Faivre-Finn C; Hatton MQ; Riesterer O; Bouvier-Morel E; Dunant A; Edwards JG; Thomas PA; Mercier O; Bardet A
Lancet Oncol; 2022 Jan; 23(1):104-114. PubMed ID: 34919827
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.
Arriagada R; Le Chevalier T; Borie F; Rivière A; Chomy P; Monnet I; Tardivon A; Viader F; Tarayre M; Benhamou S
J Natl Cancer Inst; 1995 Feb; 87(3):183-90. PubMed ID: 7707405
[TBL] [Abstract][Full Text] [Related]
14. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
[TBL] [Abstract][Full Text] [Related]
15. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
Grønberg BH; Killingberg KT; Fløtten Ø; Brustugun OT; Hornslien K; Madebo T; Langer SW; Schytte T; Nyman J; Risum S; Tsakonas G; Engleson J; Halvorsen TO
Lancet Oncol; 2021 Mar; 22(3):321-331. PubMed ID: 33662285
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
Hallqvist A; Rylander H; Björk-Eriksson T; Nyman J
Acta Oncol; 2007; 46(7):969-74. PubMed ID: 17851846
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic cranial irradiation in limited stage small cell lung cancer: survival benefit in patients with favourable characteristics.
Work E; Bentzen SM; Nielsen OS; Fode K; Michalski W; Palshof T
Eur J Cancer; 1996 May; 32A(5):772-8. PubMed ID: 9081352
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic cranial irradiation for patients with lung cancer.
Pugh TJ; Gaspar LE
Clin Lung Cancer; 2007 May; 8(6):365-8. PubMed ID: 17562236
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer.
Suwinski R; Lee SP; Withers HR
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):797-806. PubMed ID: 9531363
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
Sas-Korczyńska B; Korzeniowski S; Wójcik E
Strahlenther Onkol; 2010 Jun; 186(6):315-9. PubMed ID: 20495970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]